/Investor DB

Cobro Ventures — 2022 Investments

4 investments dated 2022 · listed companies and verified rows first · show all

Windgap Medicalwindgapmedical.cominJan 2022 · $39M

Windgap Medical develops and commercializes drug-device combination products, including a dual-chamber autoinjector technology for administering complex injectable medications.

BiotechHardwareHealthtechMedical DevicesWatertown, US

Brent Buchine(Director)inMax Meehan(Executive Officer)inAaron Mann(Executive Officer, Director)inJason Durkin(Executive Officer)inJohn Cadigan(Executive Officer)inAnthony Watson(Executive Officer)in

Co-investorsBantam GroupBoston Harbor AngelsColle Capital PartnersLaunchpad Venture GroupTaiwania Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Microbial Machines, Inc.NextRNA TherapeuticsRegenacy Pharmaceuticals

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.